Sharps Technology (NASDAQ:STSS) Upgraded by Wall Street Zen to Hold Rating

Posted by Jessica Moore on May 23rd, 2025

Wall Street Zen upgraded shares of Sharps Technology (NASDAQ:STSS – Free Report) from a strong sell rating to a hold rating in a research note published on Thursday morning.

Sharps Technology Price Performance

Shares of Sharps Technology stock opened at $3.94 on Thursday. The stock has a market capitalization of $212,760.00, a price-to-earnings ratio of -0.49 and a beta of 2.14. The business has a 50-day moving average of $16.16 and a 200 day moving average of $326.18. Sharps Technology has a 12 month low of $3.36 and a 12 month high of $5,446.32.

Sharps Technology (NASDAQ:STSS – Get Free Report) last issued its quarterly earnings results on Thursday, May 15th. The company reported $38.62 earnings per share (EPS) for the quarter.

Institutional Trading of Sharps Technology

A number of large investors have recently modified their holdings of the stock. Altium Capital Management LLC acquired a new position in Sharps Technology during the 1st quarter worth $110,000. Anson Funds Management LP grew its position in shares of Sharps Technology by 4,763.2% during the first quarter. Anson Funds Management LP now owns 1,800,000 shares of the company’s stock worth $54,000 after buying an additional 1,762,987 shares in the last quarter. Finally, Essential Planning LLC. increased its stake in shares of Sharps Technology by 22.7% during the fourth quarter. Essential Planning LLC. now owns 199,854 shares of the company’s stock worth $412,000 after buying an additional 37,029 shares during the period. Hedge funds and other institutional investors own 17.17% of the company’s stock.

Sharps Technology Company Profile

(Get Free Report)

Sharps Technology, Inc, a medical device company, researches, designs, develops, manufactures, distributes, and sells safety syringe products in the United States. It offers Sharps Provensa, an ultra-low waste space syringe for the administration of various vaccines and injectable medications. Sharps Technology, Inc was incorporated in 2017 and is based in Melville, New York.